Catherine M. Szyman Edwards Lifesciences Corp (EW) insider trading activity

Catherine M. Szyman is CVP, Critical Care of Edwards Lifesciences Corp. Currently has a direct ownership of 81,287 shares of EW, which is worth approximately $5.49 Million. The most recent transaction as insider was on Dec 17, 2021, when has been sold 10,000 shares (Common Stock) at a price of $121.24 per share, resulting in proceeds of $1,212,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.3K

7.09% 3M change

133.5% 12M change

Total Value Held $5.49 Million

Catherine M. Szyman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 17 2021	SELL Open market or private sale	$1,212,400 $121.24 p/Share	10,000 Reduced 26.73%	27,414 Common Stock
Dec 17 2021	BUY Exercise of conversion of derivative security	$217,600 $21.76 p/Share	10,000 Added 21.09%	37,414 Common Stock
Nov 18 2021	SELL Open market or private sale	$1,179,100 $117.91 p/Share	10,000 Reduced 26.73%	27,414 Common Stock
Nov 18 2021	BUY Exercise of conversion of derivative security	$217,600 $21.76 p/Share	10,000 Added 21.09%	37,414 Common Stock
Oct 18 2021	SELL Open market or private sale	$1,076,965 $110.56 p/Share	9,741 Reduced 26.22%	27,414 Common Stock
Oct 18 2021	BUY Exercise of conversion of derivative security	$211,964 $21.76 p/Share	9,741 Added 20.77%	37,155 Common Stock
Sep 08 2021	SELL Open market or private sale	$1,181,388 $121.28 p/Share	9,741 Reduced 26.22%	27,414 Common Stock
Sep 08 2021	BUY Exercise of conversion of derivative security	$211,964 $21.76 p/Share	9,741 Added 20.77%	37,155 Common Stock
Aug 05 2021	SELL Bona fide gift	-	344 Reduced 1.24%	27,414 Common Stock
Aug 02 2021	SELL Open market or private sale	$1,702,950 $113.53 p/Share	15,000 Reduced 35.08%	27,758 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$326,400 $21.76 p/Share	15,000 Added 25.97%	42,758 Common Stock
Jun 15 2021	SELL Open market or private sale	$344,990 $101.17 p/Share	3,410 Reduced 10.96%	27,704 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$76,009 $22.29 p/Share	3,410 Added 9.88%	31,114 Common Stock
May 28 2021	SELL Open market or private sale	$196,393 $95.29 p/Share	2,061 Reduced 6.92%	27,704 Common Stock
May 25 2021	SELL Open market or private sale	$448,260 $96.09 p/Share	4,665 Reduced 13.55%	29,765 Common Stock
May 17 2021	SELL Payment of exercise price or tax liability	$830,288 $89.49 p/Share	9,278 Reduced 21.23%	34,431 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	-	15,225 Added 25.83%	43,709 Common Stock
May 11 2021	SELL Payment of exercise price or tax liability	$183,331 $90.4 p/Share	2,028 Reduced 6.65%	28,484 Common Stock
May 07 2021	SELL Payment of exercise price or tax liability	$39,269 $91.75 p/Share	428 Reduced 1.25%	33,901 Common Stock
May 07 2021	SELL Open market or private sale	$311,347 $91.87 p/Share	3,389 Reduced 9.87%	30,940 Common Stock
May 07 2021	BUY Exercise of conversion of derivative security	$75,541 $22.29 p/Share	3,389 Added 8.99%	34,329 Common Stock
May 04 2021	BUY Grant, award, or other acquisition	-	3,975 Added 11.38%	30,940 Common Stock
Apr 22 2021	SELL Open market or private sale	$319,922 $94.4 p/Share	3,389 Reduced 11.16%	26,966 Common Stock
Apr 22 2021	BUY Exercise of conversion of derivative security	$75,541 $22.29 p/Share	3,389 Added 10.04%	30,355 Common Stock
Mar 15 2021	SELL Open market or private sale	$276,746 $81.66 p/Share	3,389 Reduced 11.25%	26,746 Common Stock

Also insider at

Outset Medical, Inc. Healthcare

Director

NARI

Inari Medical, Inc. Healthcare

Director

CMS